Drug harms in the UK: a multicriteria decision analysis.
about
Psychedelics and mental health: a population studyClassical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical rolesLysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trialsQuantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across ScotlandRestricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescentsRestricting or banning of alcohol advertising to reduce alcohol consumption in adults and adolescentsThe Classification of Substance Use Disorders: Historical, Contextual, and Conceptual ConsiderationsAntidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsImpact of Alcohol on Glycemic Control and Insulin ActionLegal highs: staying on top of the flood of novel psychoactive substancesDyadic social interaction inhibits cocaine-conditioned place preference and the associated activation of the accumbens corridorDysregulation of skeletal muscle protein metabolism by alcoholProteomic approaches and identification of novel therapeutic targets for alcoholismGABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidenceAltered risk-based decision making following adolescent alcohol use results from an imbalance in reinforcement learning in ratsInterventions in sports settings to reduce risky alcohol consumption and alcohol-related harm: a systematic reviewEstimating the harms of nicotine-containing products using the MCDA approachThe effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performanceJNK pathway activation is controlled by Tao/TAOK3 to modulate ethanol sensitivityPersonalized risk assessment of drug-related harm is associated with health outcomesA user's guide to cannabinoid therapies in oncologyAlcohol: taking a population perspective.Public health and international drug policy.Should the reorganization of addiction-related research across all the National Institutes of Health be structural?--The devil is truly in the details.Affective cue-induced escalation of alcohol self-administration and increased 22-kHz ultrasonic vocalizations during alcohol withdrawal: role of kappa-opioid receptors.How Should Addiction-Related Research at the National Institutes of Health be Reorganized?Re-exposure to nicotine-associated context from adolescence enhances alcohol intake in adulthood.Influence of acute alcohol ingestion on sympathetic neural responses to orthostatic stress in humansUsing patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach.Dorsolateral prefrontal cortex contributes to the impaired behavioral adaptation in alcohol dependence.The use of auricular acupuncture in opioid use disorder: A systematic literature review.Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.Beyond inhibition: a dual-process perspective to renew the exploration of binge drinking.Randomized clinical trial of the effects of screening and brief intervention for illicit drug use: the Life Shift/Shift Gears study.How Drug Control Policy and Practice Undermine Access to Controlled Medicines.Responsibility without Blame for AddictionEmergence of functional spinal delta opioid receptors after chronic ethanol exposureHarms and benefits associated with psychoactive drugs: findings of an international survey of active drug users.A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs?Early life socio-economic position and later alcohol use: birth cohort study.
P2860
Q21089784-684BC444-163E-43DD-B4E4-51ADC719160BQ22241778-119F9244-8788-4345-A1F2-F6DB77F10258Q22241828-0A597CC8-83DE-458B-9FB2-73CB7181F78FQ22242056-EEF27219-C39D-4F0B-BA1A-FF4F5DDBA8AAQ24188113-68A06C46-B206-4471-B9B6-8EC9211B40C9Q24198855-58DEA952-7B1B-4D87-B31D-8C76A7E4581EQ26739919-0A63B1E6-A753-46FE-9372-7E5732E90C2FQ26746137-7B9C3998-8ABA-4715-B364-E409EA887250Q26782992-5D44D397-61F9-4370-AE35-784311E56F3CQ26799231-E63C08D4-7B59-4D59-A917-E4B0005B4FDEQ26801871-FEE61349-5DFB-4CAC-8BE1-AB31EB17B69EQ26826554-C14213BB-4C04-4419-8D6E-449BFE754599Q27023085-0568C1FE-BFC3-40B4-B443-E3EFF21B8F25Q27026530-B64DC3A9-8FB7-4E84-A39A-5807DB4D70F6Q27302783-C49F695F-2179-4CA1-B601-5D2A56A11D7FQ28078114-0DBD1BD3-6D7D-4FD3-9563-B1364C267886Q28237791-F536D1AB-EED1-4359-9C99-2A0A79C26966Q28303831-B064C872-E175-4BC8-8DED-8D56A3C94FBBQ28485496-142D737C-9418-4911-95D6-8DE29579881CQ28534851-CB263554-95C9-4067-9EC2-203892A6EA26Q28818800-E00352A7-8734-4C44-94AE-DCE2D1BBEAA9Q30250285-76164253-37C4-43D6-89F8-5B3BC1A5F69EQ30377895-19C238FD-BAAA-4E68-B60A-C164D78C40B5Q30427534-FD86E5E7-CC80-4BF2-B5D9-A3355DB8BE7CQ30442446-6E0FAF93-C620-4DAA-BAE2-E576545E6E6CQ30453567-EB348331-9E2E-48CC-B9C7-8E987082EE7CQ30853979-644ED531-F4AD-429C-9B91-C43739835DA0Q33159728-B061D61B-A849-4A73-991D-2C96B5D329B9Q33623508-1F95A7DC-72C2-4B0D-8220-A2AB4780C15BQ33626958-DC9BA8A4-494C-4E6E-A166-1D5A10EB359FQ33686381-22263E44-043D-4BE7-B4B6-FAA9A87177B5Q33693380-7AAB8940-9C68-445A-9002-468D70A677C7Q33708623-125AEC53-9885-42C6-92EC-9CA142F91CA9Q33712846-89030470-938D-4B40-AD66-5BA2AC3490E1Q33805755-76B70A33-3654-44B2-B7C1-C0A7841D2925Q33840579-B254E013-FAA0-4399-B54C-E385D0B95B56Q33863121-1D920626-26E4-4A3E-A341-BFCD690073FCQ33937677-95B63828-4118-4249-9BFA-35D7FB177252Q34033024-6368D398-241C-4912-A688-A52D003673D0Q34114494-798BC1F5-BB60-4AC2-BE80-98BAAA899376
P2860
Drug harms in the UK: a multicriteria decision analysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Drug harms in the UK: a multicriteria decision analysis.
@ast
Drug harms in the UK: a multicriteria decision analysis.
@en
Drug harms in the UK: a multicriteria decision analysis.
@nl
type
label
Drug harms in the UK: a multicriteria decision analysis.
@ast
Drug harms in the UK: a multicriteria decision analysis.
@en
Drug harms in the UK: a multicriteria decision analysis.
@nl
prefLabel
Drug harms in the UK: a multicriteria decision analysis.
@ast
Drug harms in the UK: a multicriteria decision analysis.
@en
Drug harms in the UK: a multicriteria decision analysis.
@nl
P2093
P1433
P1476
Drug harms in the UK: a multicriteria decision analysis.
@en
P2093
Independent Scientific Committee on Drugs
Lawrence D Phillips
Leslie A King
P304
P356
10.1016/S0140-6736(10)61462-6
P407
P50
P577
2010-10-29T00:00:00Z